These results support the findings of STZ-induced alterations in muscle mass (Figure 5I) and indicate that hyperinsulinemia inhibits GR-dependent increases in atrogene expression in skeletal muscle. This evidence concerns the gene NR3C1 and Hyperinsulinemia.